Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Friday, 26'th Aug 2022
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Eli Lilly (LLY) Stock Up More Than 15% YTD: What Lies Ahead?
04:23pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Lilly (LLY) expects to launch five new medicines by 2023-end including Mounjaro for type II diabetes (already launched) and donanemab for early Alzheimer's disease.
J&J (JNJ) Gets EU Nod for Multiple Myeloma Drug Tecvayli
04:02pm, Thursday, 25'th Aug 2022 Zacks Investment Research
J&J (JNJ) gets approval for Tecvayli (teclistamab) for the treatment of relapsed and refractory multiple myeloma. This marks the first approval for Tecvayli in any country.
AstraZeneca (AZN) Gets Japan Nod for Expanded Use of 3 Drugs
03:53pm, Thursday, 25'th Aug 2022 Zacks Investment Research
The Japanese Ministry of Health, Labour, and Welfare approved AstraZeneca's (AZN) three marketed drugs, Lynparza, Tagrisso and Ultomiris, for three different indications in Japan.
Phibro (PAHC) Q4 Earnings Miss Estimates, Sales Surpass
02:56pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Phibro (PAHC) posts better-than-expected revenues for the fiscal fourth quarter, with robust growth across all segments.
1 Bear Market Blunder Investors Are Still Making
02:07pm, Thursday, 25'th Aug 2022 The Motley Fool
Focusing on the short term could lead to long-term losses.
Do Warren Buffett's Recent Moves Spell Doom for This Group of Stocks?
09:52am, Thursday, 25'th Aug 2022 The Motley Fool
The Oracle of Omaha doesn't like pharma stocks for some reason.
Is No. 1 Pharma Stock Merck A Buy As It Reportedly Mulls A Large Takeover?
04:05pm, Wednesday, 24'th Aug 2022
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?
Merck (MRK) Gets FDA Fast Track Tag for Anticoagulant Therapy
03:06pm, Wednesday, 24'th Aug 2022 Zacks Investment Research
A phase II study is ongoing on Merck's (MRK) MK-2060 in people with end-stage renal disease receiving hemodialysis.
Merck (MRK) Gets FDA Fast Track Tag for Anticoagulant Therapy
12:47pm, Wednesday, 24'th Aug 2022
A phase II study is ongoing on Merck's (MRK) MK-2060 in people with end-stage renal disease receiving hemodialysis.
Merck Looks Attractive, With or Without Seagen
09:03am, Wednesday, 24'th Aug 2022
While investors are eagerly awaiting news on a Seagen tie-up, Merck offers upside even if the deal doesn't materialize.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
06:03pm, Tuesday, 23'rd Aug 2022 Zacks Investment Research
Medtronic (MDT) posts better-than-expected results for the fiscal first quarter and maintains earnings and sales outlook for the full year.
7 High-Yield Dividend Aristocrats For The Next Market Crash
11:00am, Tuesday, 23'rd Aug 2022 Seeking Alpha
These 7 stock picks are among the world's best high-yield, low-volatility, quality aristocrats that can help you get through the next market crash. Read more.
Should Income Investors Buy This Dividend Stock?
10:55am, Tuesday, 23'rd Aug 2022 The Motley Fool
The drugmaker's stock has crushed the S&P 500 so far this year.
Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now?
10:20am, Tuesday, 23'rd Aug 2022 Zacks Investment Research
Smart Beta ETF report for FTCS
